- Home
- PAVM vs TRIB Comparison
PAVM vs TRIB Comparison
Compare PAVM & TRIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PAVM
- TRIB
- Stock Information
- Founded
- PAVM 2014
- TRIB 1992
- Country
- PAVM United States
- TRIB Ireland
- Employees
- PAVM N/A
- TRIB N/A
- Industry
- PAVM Medical/Dental Instruments
- TRIB Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- PAVM Health Care
- TRIB Health Care
- Exchange
- PAVM Nasdaq
- TRIB Nasdaq
- Market Cap
- PAVM 12.0M
- TRIB 13.0M
- IPO Year
- PAVM 2016
- TRIB N/A
- Fundamental
- Price
- PAVM $0.59
- TRIB $0.68
- Analyst Decision
- PAVM Strong Buy
- TRIB
- Analyst Count
- PAVM 1
- TRIB 0
- Target Price
- PAVM $19.00
- TRIB N/A
- AVG Volume (30 Days)
- PAVM 155.9K
- TRIB 2.4M
- Earning Date
- PAVM 08-11-2025
- TRIB 08-13-2025
- Dividend Yield
- PAVM N/A
- TRIB N/A
- EPS Growth
- PAVM N/A
- TRIB N/A
- EPS
- PAVM 0.96
- TRIB N/A
- Revenue
- PAVM $1,993,000.00
- TRIB $61,555,000.00
- Revenue This Year
- PAVM N/A
- TRIB $13.51
- Revenue Next Year
- PAVM $455.63
- TRIB $13.14
- P/E Ratio
- PAVM $0.62
- TRIB N/A
- Revenue Growth
- PAVM N/A
- TRIB 8.31
- 52 Week Low
- PAVM $0.55
- TRIB $0.48
- 52 Week High
- PAVM $1.90
- TRIB $3.44
- Technical
- Relative Strength Index (RSI)
- PAVM 41.35
- TRIB 51.77
- Support Level
- PAVM $0.59
- TRIB $0.63
- Resistance Level
- PAVM $0.63
- TRIB $0.77
- Average True Range (ATR)
- PAVM 0.04
- TRIB 0.08
- MACD
- PAVM -0.00
- TRIB 0.01
- Stochastic Oscillator
- PAVM 16.81
- TRIB 42.76
About PAVM PAVmed Inc.
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, esocheck, and the Veris Cancer Care Platform.
About TRIB Trinity Biotech plc
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.